Skip to content
Drug recall · FDA · Published February 3, 2017

Amerisource Health Services recalls GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx

Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.

🇺🇸 FDA recall #D-0520-2017DrugAmerisource Health Services ›
Take action

Contact the company & request your remedy

Recalling firmAmerisource Health Services2550 John Glenn Ave Ste A, N/A · Columbus, OH 43217-1188
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
Write-up in progress

We’re still writing up this recall

We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.

Source Page by GovInfoNow · govinfonow.com/recall/42052-amerisource-health-services-recalls-glipizide-extended-release-tablets-2-5 · Recall date February 3, 2017 · FDA enforcement record: FDA #D-0520-2017

Cite this page

“Amerisource Health Services recalls GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx.” GovInfoNow, recall dated February 3, 2017. https://govinfonow.com/recall/42052-amerisource-health-services-recalls-glipizide-extended-release-tablets-2-5. Based on FDA recall #D-0520-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0520-2017%22&limit=1).

How to tell if you have this one

  • Brand
    Amerisource Health Services
  • Category
    Drug
Take action

Contact Amerisource Health Services

We’ve drafted a message you can send Amerisource Health Services to request your refund or repair — edit it as you like.

Subject: Recall D-0520-2017 — Amerisource Health Services Amerisource Health Services recalls GlipiZIDE Extended-release tablets,

Hello,

I own a Amerisource Health Services recalls GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx that is covered by recall D-0520-2017 from Amerisource Health Services.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0520-2017 (February 3, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0520-2017 to see it in context.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA